Citigroup’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.2M Sell
60,000
-80,000
-57% -$7.66M ﹤0.01% 1941
2025
Q4
$13.4M Hold
140,000
0.01% 1337
2025
Q3
$13.3M Buy
140,000
+110,000
+367% +$10.1M 0.01% 1306
2025
Q2
$2.62M Buy
+30,000
New +$2.54M ﹤0.01% 2412
2025
Q1
Sell
-45,200
Closed -$3.61M 5802
2024
Q4
$3.61M Buy
45,200
+36,200
+402% +$3.13M ﹤0.01% 2286
2024
Q3
$810K Hold
9,000
﹤0.01% 3427
2024
Q2
$708K Sell
9,000
-22,200
-71% -$1.82M ﹤0.01% 3154
2024
Q1
$2.72M Hold
31,200
﹤0.01% 2178
2023
Q4
$2.57M Buy
31,200
+22,200
+247% +$1.69M ﹤0.01% 2035
2023
Q3
$705K Sell
9,000
-71,600
-89% -$5.99M ﹤0.01% 2791
2023
Q2
$7.1M Buy
80,600
+21,000
+35% +$1.81M ﹤0.01% 1298
2023
Q1
$4.8M Buy
+59,600
New +$4.86M ﹤0.01% 1524
2022
Q3
Sell
-400
Closed -$36K 6126
2022
Q2
$36K Sell
400
-18,600
-98% -$1.88M ﹤0.01% 4683
2022
Q1
$2.11M Sell
19,000
-11,500
-38% -$1.21M ﹤0.01% 2317
2021
Q4
$3.15M Sell
30,500
-10,300
-25% -$1.19M ﹤0.01% 2224
2021
Q3
$5.11M Sell
40,800
-1,100
-3% -$142K ﹤0.01% 1817
2021
Q2
$5.2M Buy
41,900
+1,800
+4% +$226K ﹤0.01% 1857
2021
Q1
$4.74M Sell
40,100
-136,400
-77% -$16M ﹤0.01% 1815
2020
Q4
$20.7M Sell
176,500
-29,400
-14% -$3.24M 0.01% 1012
2020
Q3
$21.4M Buy
205,900
+61,900
+43% +$6.22M 0.01% 870
2020
Q2
$13.2M Sell
144,000
-279,800
-66% -$26.8M 0.01% 1119
2020
Q1
$38.2M Sell
423,800
-24,000
-5% -$2.55M 0.03% 461
2019
Q4
$50.8M Sell
447,800
-12,700
-3% -$1.39M 0.04% 503
2019
Q3
$50M Sell
460,500
-212,900
-32% -$22.2M 0.04% 458
2019
Q2
$65.6M Buy
673,400
+562,600
+508% +$51.4M 0.05% 349
2019
Q1
$10.1M Sell
110,800
-117,500
-51% -$10.5M 0.01% 1261
2018
Q4
$20.8M Buy
228,300
+21,300
+10% +$1.99M 0.02% 810
2018
Q3
$20.4M Sell
207,000
-1,193,800
-85% -$110M 0.02% 825
2018
Q2
$120M Buy
1,400,800
+1,189,000
+561% +$99.3M 0.11% 149
2018
Q1
$17M Sell
211,800
-243,200
-53% -$20.1M 0.01% 880
2017
Q4
$36.7M Buy
455,000
+201,100
+79% +$16.1M 0.03% 543
2017
Q3
$19.7M Buy
253,900
+16,600
+7% +$1.38M 0.02% 801
2017
Q2
$21.1M Buy
237,300
+118,800
+100% +$10M 0.02% 725
2017
Q1
$9.55M Buy
118,500
+90
+0.1% +$7.03K 0.01% 1168
2016
Q4
$8.44M Sell
118,410
-18,300
-13% -$1.44M 0.01% 1332
2016
Q3
$11.8M Sell
136,710
-120,840
-47% -$10.5M 0.01% 977
2016
Q2
$22.3M Buy
257,550
+38,500
+18% +$3.11M 0.02% 596
2016
Q1
$16.4M Sell
219,050
-31,360
-13% -$2.36M 0.02% 701
2015
Q4
$19.3M Sell
250,410
-151,455
-38% -$11.4M 0.02% 747
2015
Q3
$26.9M Buy
401,865
+114,965
+40% +$8.47M 0.03% 582
2015
Q2
$21.3M Sell
286,900
-32,870
-10% -$2.51M 0.02% 747
2015
Q1
$24.9M Buy
319,770
+48,070
+18% +$3.64M 0.02% 658
2014
Q4
$19.6M Sell
271,700
-67,800
-20% -$4.71M 0.02% 822
2014
Q3
$21M Sell
339,500
-52,900
-13% -$3.36M 0.02% 770
2014
Q2
$25M Sell
392,400
-155,700
-28% -$9.46M 0.02% 656
2014
Q1
$33.7M Buy
548,100
+309,400
+130% +$18M 0.03% 471
2013
Q4
$13.7M Sell
238,700
-64,700
-21% -$3.67M 0.01% 998
2013
Q3
$16.2M Buy
303,400
+34,500
+13% +$1.86M 0.02% 847
2013
Q2
$13.8M Buy
+268,900
New +$13.3M 0.01% 870

Other funds holding MDT

Citigroup's MDT Position: Q1 2026 in Review

Citigroup increased its Medtronic (MDT) stake by 4.2% in Q1 2026, buying an estimated $5.22M and bringing the position to 1,337,911 shares worth $116M. The position accounts for 0.05% of the portfolio, ranked #359.

Citigroup first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $309M in Q2 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Citigroup held 1,337,911 shares of Medtronic worth $116M as of Q1 2026.
  • Citigroup bought 54,444 Medtronic shares in Q1 2026, an estimated $5.22M.
  • Medtronic made up 0.05% of Citigroup's portfolio in Q1 2026, its #359 holding.
  • Citigroup first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Medtronic position peaked at $309M in Q2 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.